Latest Grant/GrossMendelsohn, LLC Stock Portfolio

Grant/GrossMendelsohn, LLC Performance:
2025 Q1: -0.05%YTD: -0.05%2024: 4.46%

Performance for 2025 Q1 is -0.05%, and YTD is -0.05%, and 2024 is 4.46%.

About Grant/GrossMendelsohn, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Grant/GrossMendelsohn, LLC reported an equity portfolio of $179.9 Millions as of 31 Mar, 2025.

The top stock holdings of Grant/GrossMendelsohn, LLC are ACWF, GLD, TAGG. The fund has invested 9.9% of it's portfolio in ISHARES TR and 8.4% of portfolio in SPDR GOLD TR.

The fund managers got completely rid off JANUS DETROIT STR TR (JAAA), FIDELITY COVINGTON TRUST (FBCG) and INVESCO EXCHANGE TRADED FD T (CSD) stocks. They significantly reduced their stock positions in TARSUS PHARMACEUTICALS INC (TARS), AMERICAN CENTY ETF TR (AEMB) and FIRST TR EXCH TRADED FD III (FCAL). Grant/GrossMendelsohn, LLC opened new stock positions in FIDELITY COVINGTON TRUST (FBCG), ISHARES TR (AAXJ) and VANGUARD INSTL INDEX FD. The fund showed a lot of confidence in some stocks as they added substantially to FIDELITY COVINGTON TRUST (FBCG), FIRST TR EXCHANGE-TRADED FD (LEGR) and ISHARES TR (AAXJ).

Grant/GrossMendelsohn, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Grant/GrossMendelsohn, LLC made a return of -0.05% in the last quarter. In trailing 12 months, it's portfolio return was 2.27%.
20212022202320242025−20−100102030Performance (%)PerformanceS&P 500

New Buys

Ticker$ Bought
fidelity covington trust3,124,430
fidelity covington trust2,961,150
ishares tr2,749,030
principal exchange traded fd633,116
vanguard instl index fd340,249
legg mason etf invt302,821
select sector spdr tr278,894
select sector spdr tr233,831

New stocks bought by Grant/GrossMendelsohn, LLC

Additions

Ticker% Inc.
fidelity covington trust1,132
first tr exchange-traded fd339
ishares tr311
robinhood mkts inc183
rxsight inc128
adverum biotechnologies inc90.27
first tr exchange-traded fd65.65
first tr exch traded fd iii55.66

Additions to existing portfolio by Grant/GrossMendelsohn, LLC

Reductions

Ticker% Reduced
tarsus pharmaceuticals inc-66.52
american centy etf tr-31.36
first tr exch traded fd iii-29.1
proshares tr-22.82
f n b corp-21.3
select sector spdr tr-17.96
listed fd tr-17.17
ishares tr-16.78

Grant/GrossMendelsohn, LLC reduced stake in above stock

Sold off

Ticker$ Sold
janus detroit str tr-5,808,530
invesco exchange traded fd t-3,151,160
fidelity covington trust-3,255,780
sinclair inc-604,996
fidelity covington trust-3,221,740
ishares tr-3,003,380
medical pptys trust inc-100,219
fidelity merrimack str tr-67,892

Grant/GrossMendelsohn, LLC got rid off the above stocks

Sector Distribution

Grant/GrossMendelsohn, LLC has about 73.7% of it's holdings in Others sector.

74%
Sector%
Others73.7
Technology9.1
Healthcare4.1
Financial Services2.7
Consumer Defensive2.7
Industrials2.6
Consumer Cyclical1.5
Communication Services1.4
Utilities1.1
Energy1.1

Market Cap. Distribution

Grant/GrossMendelsohn, LLC has about 23.3% of it's portfolio invested in the large-cap and mega-cap stocks.

74%16%
Category%
UNALLOCATED73.7
MEGA-CAP15.6
LARGE-CAP7.7
SMALL-CAP2.4

Stocks belong to which Index?

About 25% of the stocks held by Grant/GrossMendelsohn, LLC either belong to S&P 500 or RUSSELL 2000 index.

75%23%
Index%
Others75
S&P 50022.5
RUSSELL 20002.5
Top 5 Winners (%)%
CVS
cvs health corp
44.7 %
GLD
spdr gold tr
27.3 %
EXC
exelon corp
23.2 %
GE
ge aerospace
19.9 %
T
at&t inc
19.7 %
Top 5 Winners ($)$
GLD
spdr gold tr
3.2 M
ABT
abbott labs
0.1 M
MCD
mcdonalds corp
0.1 M
CVS
cvs health corp
0.1 M
ABBV
abbvie inc
0.1 M
Top 5 Losers (%)%
RXST
rxsight inc
-40.9 %
ADVM
adverum biotechnologies inc
-25.2 %
FDX
fedex corp
-25.2 %
DIS
disney walt co
-19.0 %
TMO
thermo fisher scientific inc
-19.0 %
Top 5 Losers ($)$
ORCL
oracle corp
-0.9 M
AAPL
apple inc
-0.6 M
NVDA
nvidia corporation
-0.6 M
MSFT
microsoft corp
-0.2 M
TARS
tarsus pharmaceuticals inc
-0.2 M

Grant/GrossMendelsohn, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

ACWFGLDTAGGBBAXORCLVBAFTYIJRFNDAFNDAFBCGAAPLFBCGFBCGMSFTFNDAAAXJAAXJFMBPABBBSINVDADWMFBNDWJPMLEGRCSDPGXOMSP..AB..HO..AA....IBCEAFTYIJRIJRMC..AB..IB..V..VBAFLGFNDAGOOGCO..VB..

Current Stock Holdings of Grant/GrossMendelsohn, LLC

Grant/GrossMendelsohn, LLC has 133 stocks in it's portfolio. About 39.2% of the portfolio is in top 10 stocks. ORCL proved to be the most loss making stock for the portfolio. GLD was the most profitable stock for Grant/GrossMendelsohn, LLC last quarter.

Last Reported on: 01 May, 2025
TickerNamesorted descending% PortfolioShares Held$ ValueType% ChangeOptions

Historical Trend of ISHARES TR Position Held By Grant/GrossMendelsohn, LLC

What % of Portfolio is ACWF?:

Number of ACWF shares held:

Change in No. of Shares Held: